Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20082
20094
20103
20161
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
AstraZeneca2
Eli Lilly and Company2
Bristol-Myers Squibb1
CSL Behring1
DalCor Pharmaceuticals1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome14
Heart Diseases4
Myocardial Infarction4
Cardiovascular Diseases3
Stroke3
Angina, Unstable2
Atherosclerosis2
Coronary Artery Disease2
Atrial Fibrillation1
Coronary Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.